21. March 2023
On March 3, 2023, Bachem (SIX: BANB) announced the conclusion of a new framework agreement with an undisclosed customer for the supply of large quantities of peptides following the successful completion of a joint development project.
On March 3, 2023, Bachem (SIX: BANB) announced the conclusion of a new framework agreement with an undisclosed customer for the supply of large quantities of peptides following the successful completion of a joint development project. The contract includes a binding order volume worth over CHF 500 million for the five-year period 2027-2031, with significant upside potential. Wenger Plattner (Dr. Tobias Meili) supported Bachem in negotiating the framework agreement as well as aspects of the SIX listing regulations.
Stay up to date and subscribe to our Newsletter.